Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting of NLRP3 inflammasome with gene editing for the amelioration of inflammatory diseases
Cong‐Fei Xu, Zi-Dong Lu, Ying‐Li Luo, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 173

Showing 26-50 of 173 citing articles:

The Pyroptotic Cell Death Effector Gasdermin D Is Activated by Gout-Associated Uric Acid Crystals but Is Dispensable for Cell Death and IL-1β Release
Maryam Rashidi, Daniel S. Simpson, Anne Hempel, et al.
The Journal of Immunology (2019) Vol. 203, Iss. 3, pp. 736-748
Open Access | Times Cited: 110
Material solutions for delivery of CRISPR/Cas-based genome editing tools: Current status and future outlook
Tao Wan, Dong Niu, Chuanbin Wu, et al.
Materials Today (2019) Vol. 26, pp. 40-66
Closed Access | Times Cited: 107
Macrophage Modification Strategies for Efficient Cell Therapy
Anastasiya S. Poltavets, Polina Vishnyakova, Andrey Elchaninov, et al.
Cells (2020) Vol. 9, Iss. 6, pp. 1535-1535
Open Access | Times Cited: 99
Delivery of Tissue-Targeted Scalpels: Opportunities and Challenges for In Vivo CRISPR/Cas-Based Genome Editing
Tuo Wei, Qiang Cheng, Lukas Farbiak, et al.
ACS Nano (2020) Vol. 14, Iss. 8, pp. 9243-9262
Open Access | Times Cited: 97
Human Autoinflammatory Diseases Mediated by NLRP3-, Pyrin-, NLRP1-, and NLRC4-Inflammasome Dysregulation Updates on Diagnosis, Treatment, and the Respective Roles of IL-1 and IL-18
Sara Alehashemi, Raphaela Goldbach‐Mansky
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 93
Macrophage Sphingosine 1-Phosphate Receptor 2 Blockade Attenuates Liver Inflammation and Fibrogenesis Triggered by NLRP3 Inflammasome
Lei Hou, Le Yang, Na Chang, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 88
Bacteroides fragilis restricts colitis-associated cancer via negative regulation of the NLRP3 axis
Xinyu Shao, Shishuo Sun, Yuqing Zhou, et al.
Cancer Letters (2021) Vol. 523, pp. 170-181
Open Access | Times Cited: 87
Gastrodin Alleviates Cognitive Dysfunction and Depressive-Like Behaviors by Inhibiting ER Stress and NLRP3 Inflammasome Activation in db/db Mice
Tianyuan Ye, Xiangbao Meng, Ruiying Wang, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 12, pp. 3977-3977
Open Access | Times Cited: 86
Adipose tissue in health and disease
Innocence Harvey, Anik Boudreau, Jacqueline M. Stephens
Open Biology (2020) Vol. 10, Iss. 12
Open Access | Times Cited: 76
Ultrasound-Controlled CRISPR/Cas9 System Augments Sonodynamic Therapy of Hepatocellular Carcinoma
Haohao Yin, Liping Sun, Yinying Pu, et al.
ACS Central Science (2021) Vol. 7, Iss. 12, pp. 2049-2062
Open Access | Times Cited: 70
Novel Strategy to Combat Antibiotic Resistance: A Sight into the Combination of CRISPR/Cas9 and Nanoparticles
Fen Wan, Mohamed S. Draz, Mengjie Gu, et al.
Pharmaceutics (2021) Vol. 13, Iss. 3, pp. 352-352
Open Access | Times Cited: 62
Recent Advances and Challenges in Gene Delivery Mediated by Polyester-Based Nanoparticles
Anna Piperno, Maria Teresa Sciortino, Elena Giusto, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 5981-6002
Open Access | Times Cited: 62
Interleukin-1 in obesity-related low-grade inflammation: From molecular mechanisms to therapeutic strategies
Mohammad Ghanbari, Salar Momen Maragheh, Aida Aghazadeh, et al.
International Immunopharmacology (2021) Vol. 96, pp. 107765-107765
Closed Access | Times Cited: 60
Genome-editing prodrug: Targeted delivery and conditional stabilization of CRISPR-Cas9 for precision therapy of inflammatory disease
Xiaojie Yan, Qi Pan, Huhu Xin, et al.
Science Advances (2021) Vol. 7, Iss. 50
Open Access | Times Cited: 60
Targeted Inhibition of FTO Demethylase Protects Mice Against LPS-Induced Septic Shock by Suppressing NLRP3 Inflammasome
Jia‐Hui Luo, Faxi Wang, Fei Sun, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 59
Nonantimicrobial Actions of Macrolides: Overview and Perspectives for Future Development
Jennifer Kricker, Clive P. Page, Fridrik Runar Gardarsson, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 4, pp. 1404-1433
Open Access | Times Cited: 59
Delivery of mRNA for regulating functions of immune cells
Jia Shi, Mengwen Huang, Zi-Dong Lu, et al.
Journal of Controlled Release (2022) Vol. 345, pp. 494-511
Open Access | Times Cited: 43
pH‐Responsive Polymer Nanoparticles for Efficient Delivery of Cas9 Ribonucleoprotein With or Without Donor DNA
Ruosen Xie, Xiuxiu Wang, Yuyuan Wang, et al.
Advanced Materials (2022) Vol. 34, Iss. 23
Open Access | Times Cited: 41
Current updates of CRISPR/Cas9‐mediated genome editing and targeting within tumor cells: an innovative strategy of cancer management
Khaled S. Allemailem, Mohammed A. Alsahli, Ahmad Almatroudi, et al.
Cancer Communications (2022) Vol. 42, Iss. 12, pp. 1257-1287
Open Access | Times Cited: 39
Precision Nanotoxicology in Drug Development: Current Trends and Challenges in Safety and Toxicity Implications of Customized Multifunctional Nanocarriers for Drug-Delivery Applications
Anas Ahmad, Mohammad Imran, Nisha Sharma
Pharmaceutics (2022) Vol. 14, Iss. 11, pp. 2463-2463
Open Access | Times Cited: 39
Role of the inflammasome in insulin resistance and type 2 diabetes mellitus
Shen Lu, Yanrong Li, Zhaojun Qian, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 39
Unraveling the potential of 3D bioprinted immunomodulatory materials for regulating macrophage polarization: State-of-the-art in bone and associated tissue regeneration
Sayan Deb Dutta, Tejal V. Patil, Keya Ganguly, et al.
Bioactive Materials (2023) Vol. 28, pp. 284-310
Open Access | Times Cited: 27
Delivery of nucleic acid based genome editing platforms via lipid nanoparticles: Clinical applications
Razan Masarwy, Lior Stotsky‐Oterin, Aviad Elisha, et al.
Advanced Drug Delivery Reviews (2024) Vol. 211, pp. 115359-115359
Closed Access | Times Cited: 16
Cryo-shocked tumor cells deliver CRISPR-Cas9 for lung cancer regression by synthetic lethality
F Liu, Minhang Xin, Huiheng Feng, et al.
Science Advances (2024) Vol. 10, Iss. 13
Open Access | Times Cited: 15
Stimulus-Responsive Drug Delivery Nanoplatforms for Inflammatory Bowel Disease Therapy
Long Jiang, Xiaoya Liang, Zuojin Ao, et al.
Acta Biomaterialia (2024)
Closed Access | Times Cited: 12

Scroll to top